213 related articles for article (PubMed ID: 33527196)
21. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
Cui G; Yuan A; Li Z; Goll R; Florholmen J
Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094
[TBL] [Abstract][Full Text] [Related]
22. ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
Metzger TC; Long H; Potluri S; Pertel T; Bailey-Bucktrout SL; Lin JC; Fu T; Sharma P; Allison JP; Feldman RM
Cancer Res; 2016 Jul; 76(13):3684-9. PubMed ID: 27197182
[TBL] [Abstract][Full Text] [Related]
23. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8
Cagnoni AJ; Giribaldi ML; Blidner AG; Cutine AM; Gatto SG; Morales RM; Salatino M; Abba MC; Croci DO; Mariño KV; Rabinovich GA
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006646
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting OX40 Restores Regulatory T-Cell Function and Suppresses Inflammation in Pulmonary Sarcoidosis.
Kumari R; Chakraborty S; Jain R; Mitra S; Mohan A; Guleria R; Pandey S; Chaudhury U; Mitra DK
Chest; 2021 Sep; 160(3):969-982. PubMed ID: 33901497
[TBL] [Abstract][Full Text] [Related]
25. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.
Xiao X; Gong W; Demirci G; Liu W; Spoerl S; Chu X; Bishop DK; Turka LA; Li XC
J Immunol; 2012 Jan; 188(2):892-901. PubMed ID: 22147766
[TBL] [Abstract][Full Text] [Related]
26. Increased tumor-infiltrating CD45RA
Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
[TBL] [Abstract][Full Text] [Related]
27. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer.
Waniczek D; Lorenc Z; Śnietura M; Wesecki M; Kopec A; Muc-Wierzgoń M
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):445-454. PubMed ID: 28343267
[TBL] [Abstract][Full Text] [Related]
28. Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf.
Fantini MC; Favale A; Onali S; Facciotti F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937953
[TBL] [Abstract][Full Text] [Related]
29. Imbalance between Subpopulations of Regulatory T Cells in Patients with Acute Exacerbation of COPD.
Yang X; Huo B; Zhong X; Su W; Liu W; Li Y; He Z; Bai J
COPD; 2017 Dec; 14(6):618-625. PubMed ID: 29166179
[TBL] [Abstract][Full Text] [Related]
30. OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function.
Polesso F; Sarker M; Weinberg AD; Murray SE; Moran AE
J Immunol; 2019 Oct; 203(7):2011-2019. PubMed ID: 31434709
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD30 and Ox40 on T lymphocyte subsets is controlled by distinct regulatory mechanisms.
Toennies HM; Green JM; Arch RH
J Leukoc Biol; 2004 Feb; 75(2):350-7. PubMed ID: 14634058
[TBL] [Abstract][Full Text] [Related]
32. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.
Bresson D; Fousteri G; Manenkova Y; Croft M; von Herrath M
J Autoimmun; 2011 Dec; 37(4):342-51. PubMed ID: 22063316
[TBL] [Abstract][Full Text] [Related]
33. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
[TBL] [Abstract][Full Text] [Related]
34. Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signaling.
Kumar P; Alharshawi K; Bhattacharya P; Marinelarena A; Haddad C; Sun Z; Chiba S; Epstein AL; Prabhakar BS
Sci Rep; 2017 Jan; 7():39751. PubMed ID: 28045060
[TBL] [Abstract][Full Text] [Related]
35. Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus.
Mesquita D; Cruvinel WM; Araujo JA; Salmazi KC; Kallas EG; Andrade LE
Braz J Med Biol Res; 2014 Aug; 47(8):662-9. PubMed ID: 25098715
[TBL] [Abstract][Full Text] [Related]
36. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
Kitamura N; Murata S; Ueki T; Mekata E; Reilly RT; Jaffee EM; Tani T
Int J Cancer; 2009 Aug; 125(3):630-8. PubMed ID: 19455675
[TBL] [Abstract][Full Text] [Related]
37. Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge.
Bekiaris V; Gaspal F; Kim MY; Withers DR; Sweet C; Anderson G; Lane PJ
Eur J Immunol; 2009 Aug; 39(8):2120-5. PubMed ID: 19609980
[TBL] [Abstract][Full Text] [Related]
38. CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells.
Guercio M; Orlando D; Di Cecca S; Sinibaldi M; Boffa I; Caruso S; Abbaszadeh Z; Camera A; Cembrola B; Bovetti K; Manni S; Caruana I; Ciccone R; Del Bufalo F; Merli P; Vinti L; Girardi K; Ruggeri A; De Stefanis C; Pezzullo M; Giorda E; Scarsella M; De Vito R; Barresi S; Ciolfi A; Tartaglia M; Moretta L; Locatelli F; Quintarelli C; De Angelis B
Haematologica; 2021 Apr; 106(4):987-999. PubMed ID: 32381575
[TBL] [Abstract][Full Text] [Related]
39. A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2.
Piconese S; Pittoni P; Burocchi A; Gorzanelli A; Carè A; Tripodo C; Colombo MP
Eur J Immunol; 2010 Oct; 40(10):2902-13. PubMed ID: 20806292
[TBL] [Abstract][Full Text] [Related]
40. Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity.
Nawaf MG; Ulvmar MH; Withers DR; McConnell FM; Gaspal FM; Webb GJ; Jones ND; Yagita H; Allison JP; Lane PJL
J Immunol; 2017 Aug; 199(3):974-981. PubMed ID: 28646041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
